Login

Anders Hultman, CEO, AroCell AB (publ) 00:00:00

Share On Facebook Share On Twitter

CEO Anders Hultman presents Arocell

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
AirAsia’s Journey: From Asia’s Biggest Budget Airline to the Brink of Bankruptcy During COVID-19 | Tony Fernandes, CEO, AirAsia Bhd.
00:10:00
Unveiling the Vision: Mario Gabril, CEO of GAMCO Investor | Mario J. Gabelli, Chief Executive Officer , Gamco Investors Inc.
00:10:00
Female Founders are shaping China's Innovation Landscape with|Xu Ying,General Partner,Vertex Ventures
00:10:00
William Huang, chairman, founder, and CEO of GDS Holdings, discusses his Chinese data center company's IPO and growth strategy.
00:10:00
Azure Minerals: Advanced Zinc-Lead-Silver Project in Sonora
00:10:00
Jan Bredack on Building Veganz: From Skepticism to Success | Jan Bredack, CEO , Veganz Group AG.
00:10:00
Ely Gold Royalties CEO Trey Wasser Discusses Market Trends and Company Growth
00:10:00
Simplifying Options for Consumers in the Clean Energy Future | Jeffrey B. Guldner, CEO , Arizona Public Service.
00:10:00
Travel Trends & Hybrid Work: Insights from BLADE's CEO | Robert S Wiesenthal - CEO of Blade Air Mobility Inc.
00:10:00
Revolutionizing Healthcare Through Genetic Transparency and Choice|Anne Wojcicki, CEO, 23andme holding co.
00:10:00
Private Credit's Ascent: Navigating Opportunities as Banks Retreat
00:10:00
Overview of Water and Sanitation Infrastructure Investments and Developments in Paraná | Claudio Stabile, CEO, Companhia de Saneamento do Parana Sanepar.

© 2026 Nehu